Investing.com - Financial Markets Worldwide

Roche Holding AG Participation (ROG)

Symbol
Exchange
Currency
ROG
SwitzerlandCHFDelayed
RO
SwitzerlandCHFDelayed
ROGz
BATS EuropeCHFDelayed
ROz
BATS EuropeCHFDelayed
RHHBY
OTC MarketsUSDDelayed
RHHVF
OTC MarketsUSDDelayed
0QQ6
LondonCHFReal-time
0QOK
LondonCHFReal-time
ROGN
MexicoMXNDelayed
RHO6y
FrankfurtEURDelayed
RO
FrankfurtEURDelayed
323.45
+3.20(+1.00%)
-Closed.
Currency in CHF
  • Volume:
    1,185,152
  • Bid/Ask:
    323.40/323.45
  • Day's Range:
    319.25 - 324.00

ROG Overview

Prev. Close
320.25
Day's Range
319.25-324
Revenue
62.8B
Open
321.25
52 wk Range
298.65-404.15
EPS
17.85
Volume
1,185,152
Market Cap
266.02B
Dividend (Yield)
9.30
(2.88%)
Average Vol. (3m)
978,520
P/E Ratio
19.29
Beta
0.297
1-Year Change
-5.41%
Shares Outstanding
801,094,291
Next Earnings Date
Oct 18, 2022
What is your sentiment on Roche Holding Participation?
or
Market is currently closed. Voting is open during market hours.

Roche Holding AG Participation News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Roche Holding AG Participation Analysis

Roche Holding AG Participation Company Profile

Roche Holding AG Participation Company Profile

Industry
Pharmaceuticals
Sector
Healthcare
Employees
100920
Market
Switzerland
  • Type:Equity
  • Market:Switzerland
  • ISIN:CH0012032048
  • S/N:1203204

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. It has a research collaboration agreement with Synlogic, Inc. for the discovery of a novel synthetic biotic for the treatment of inflammatory bowel disease (IBD). The company was founded in 1896 and is headquartered in Basel, Switzerland.

Read More

Income Statement

Analyst Price Target

Average376.25 (+16.32% Upside)
High450
Low300
Price323.45
No. of Analysts25
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyBuyBuy
Technical IndicatorsStrong BuyStrong BuyStrong BuyNeutralStrong Sell
SummaryStrong BuyStrong BuyStrong BuyNeutralNeutral

Trending Stocks

Trending Stocks

Name
Last
High
Low
Chg.
Chg. %
Vol.
Time
British American Tobacco ADR
35.5036.1535.48-0.48-1.33%3.05MNYSE
Tesla
265.25275.57262.47-2.96-1.10%66.83MNASDAQ
Pfizer
43.7644.6043.73-0.40-0.91%22.87MNYSE
Citigroup
41.6742.9741.61-0.72-1.70%22.13MNYSE
AT&T
15.3415.6815.34-0.19-1.22%62.86MNYSE
Microsoft
232.90240.54232.73-4.60-1.94%35.48MNASDAQ
AstraZeneca ADR
54.8455.7254.76-0.07-0.13%7.52MNASDAQ
Kimberly-Clark
112.54115.96112.38-2.44-2.12%2.28MNYSE
GameStop Corp
25.1325.8224.44-0.33-1.30%3.06MNYSE
Illumina
190.79194.22183.65-3.02-1.56%2.77MNASDAQ
Oracle
61.0762.1461.06-0.33-0.54%9.71MNYSE
Taiwan Semiconductor
68.5669.6567.74-0.72-1.04%10.42MNYSE
First Majestic Silver
7.627.787.17+0.37+5.10%8.42MNYSE
BlackBerry
4.704.884.70-0.10-2.08%4.89MNYSE
Fifth Third
31.9632.8231.84-0.09-0.28%6.14MNASDAQ
  • Whatever type of investment you decide to get into,i think the key message here or for me rather is to start investing no matter how small and that’s why I recommend➡️ FACE📚BOOK 👉S’T’E’P’H’A’N’I’E_M_R’Y’A’N official trade She changed my life I recommend her for her good works, you can quickly con'tact her on, WhAAt👤APP ➡️+1 ✅(201)✅389-✅8652
    0
    • macd indicators showing a nice jump coming, keeping my fingers crossed during these dark times
      0
      • What happened today?
        0
        • The SKYSCRAPER-01 study evaluating tiragolumab plus Tecentriq did not meet its co-primary endpoint of progression-free survival
          0
        • Today only this info about Roche
          0
      • A large pharmaceutical company, by the name of R. , is pushing down the value of the Spanish company's Pharmamar share price through the funds Consonance Capital and Great Point Partners, so that the biotech company accepts its offer of more than 4500 million dollars.According to this pharma, Pharmamar's products have a great future in oncology and virology, and would be fully engaged in its search for new drugs.
        4
        • hello to Marinopoulos Pharma company .!
          0
      • Trades ex dividend!!
        0
        • Currently near to Fibo 61.8 levels, a great company to buy IMO.
          0
          • Any comments?
            0
            • Still holding, not a good stock tho..
              2
          • cant make it even during pandemic, sell
            2
            • I've invested in Roche.VX, is it the right stock?
              0
              • Which one is the real Roche stock? I found out today that a big company in Germany is buying covid tests from Roche but i don't know for sure in which stock should i invest.  The stock will go surely up but i wanna be in the right one. I've invested in this one but i am not sure if it's the real one because i heard a rumour and they said that the tests are coming from FRANCE. If someone can help me understand, thank you.
                4
                • CH:ROG
                  0
                • nevertheess, i would buy below 300. its probably gonna test there. roche is not perfoming at its best at the moment. when buy now the longterm ... because dividends are pretty good here. if you hold 20 years - the dividends would have paid you back the amount you spend now
                  0
                • france = Sanofi is not Roche
                  0